Centessa Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	395.03	128.03	393.64	595.08	7.23	-
Short-Term Investments	123.42	128.52	-	-	-	-
Cash & Short-Term Investments	518.45	256.55	393.64	595.08	7.23	-
Cash Growth	84.28%	-34.83%	-33.85%	8134.15%	-	-
Other Receivables	40.04	39.15	26.72	16.81	2.93	-
Receivables	40.04	39.15	26.72	16.81	2.93	-
Prepaid Expenses	1.37	1.65	2.79	4.66	0.01	-
Other Current Assets	8.51	17.74	14.59	12.22	1	-
Total Current Assets	568.36	315.09	437.75	628.77	11.17	-
Property, Plant & Equipment	12.07	12.95	1.17	0.16	-	-
Long-Term Deferred Tax Assets	27.06	29.65	3.51	-	-	-
Other Long-Term Assets	2.23	2.55	1.88	0.7	0.55	-
Total Assets	609.72	360.25	444.31	629.64	11.72	-
Accounts Payable	7.44	11.82	13.84	8.07	1.03	-
Accrued Expenses	17.97	26.62	22.23	15.7	1.04	-
Short-Term Debt	-	-	-	-	5.63	-
Current Portion of Leases	0.58	0.51	-	-	-	-
Current Income Taxes Payable	-	0.11	1.58	0.77	-	-
Other Current Liabilities	0.41	0.33	0.69	0.1	0.92	-
Total Current Liabilities	26.41	39.39	38.34	24.64	8.62	-
Long-Term Debt	75.7	75.7	69.8	75.7	-	-
Long-Term Leases	8.44	8.89	-	-	-	-
Other Long-Term Liabilities	0.03	0.03	-	37.74	-	-
Total Liabilities	110.58	124	108.14	138.08	8.62	-
Common Stock	0.36	0.27	0.27	0.25	25.55	-
Additional Paid-In Capital	1,374	987.42	939.26	876.27	0.83	-
Retained Earnings	-877.37	-752.95	-601.86	-385.65	-23.85	-
Comprehensive Income & Other	2.1	1.49	-1.5	0.69	0.57	-
Shareholders' Equity	499.14	236.24	336.17	491.55	3.1	-
Total Liabilities & Equity	609.72	360.25	444.31	629.64	11.72	-
Total Debt	84.72	85.09	69.8	75.7	5.63	-
Net Cash (Debt)	433.73	171.46	323.84	519.38	1.6	-
Net Cash Growth	119.23%	-47.06%	-37.65%	32361.38%	-	-
Net Cash Per Share	4.10	1.78	3.47	6.91	0.11	-
Filing Date Shares Outstanding	131.85	100.31	94.96	94.02	15	-
Total Common Shares Outstanding	131.66	98.77	94.84	89.99	15	-
Working Capital	541.96	275.71	399.41	604.14	2.55	-
Book Value Per Share	3.79	2.39	3.54	5.46	0.21	-
Tangible Book Value	499.14	236.24	336.17	491.55	3.1	-
Tangible Book Value Per Share	3.79	2.39	3.54	5.46	0.21	-
Machinery	1.49	1.5	0.44	0.2	-	-
Construction In Progress	-	-	0.89	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.